Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04059718 · ClinicalTrials.gov registry record · NA

SCI Thrive: Efficacy of a Peer-led Online Self-Management Program

A NA study, sponsored by University of Washington.

Completed
Registry status
NA
Development phase
184
Enrollment target

NCT04059718: Completed NA study, sponsored by University of Washington.

NCT04059718 is a NA study that has completed, run by University of Washington. The registered enrollment target is 184 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04059718, a NA study, has completed, sponsored by University of Washington.

COMPLETED
Registry status
NA
Development phase
184 participants
Enrollment target

Study Summary

SCI Thrive is a randomized controlled trial to test the efficacy of SCI Thrive (6 week Peer-Led Online Self-Management Program) to improve quality of life and self-efficacy for individuals with SCI.

Primary Outcome

The PQOL measures satisfaction with 12 different aspects of life including an individual's contact with family or friends, contribution to the community, meaning and purpose in life, and happiness.

Interventions

  • BEHAVIORAL SCI Thrive Peer-Led Online Self-Management Program

Trial Details

FieldValue
Enrollment Target 184 participants
Start Date 2019-10-01
Est. Completion 2021-12-24
Phase NA
University of Washington

1,048 total trials

What the finished NCT04059718 record still lists

NCT04059718 is an interventional study that assigns participants to a tested intervention. The registered 184 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).

The record links to 0 conditions, and to 1 intervention - of which SCI Thrive Peer-Led Online Self-Management Program is the first listed.

NCT04059718 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04059718 about?

NCT04059718 is a clinical study titled "SCI Thrive: Efficacy of a Peer-led Online Self-Management Program". SCI Thrive is a randomized controlled trial to test the efficacy of SCI Thrive (6 week Peer-Led Online Self-Management Program) to improve quality of life and self-efficacy for individuals with SCI.

What is the current status of trial NCT04059718?

This trial is currently completed. It is a NA study. The enrollment target is 184 participants. The study started on 2019-10-01. Estimated completion is 2021-12-24.

What interventions are being tested in trial NCT04059718?

The interventions under investigation include: SCI Thrive Peer-Led Online Self-Management Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT04059718?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04059718's enrollment target sits among peer trials

184 581st of 2000 higher than 1,417 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03903510 · 184 participants · NA

    Virtual Reality During Pediatric Cast Removal

  • NCT04020510 · 184 participants · Phase 4

    Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive Bladder

  • NCT04135846 · 184 participants · Phase 2

    Alpha-1 Blockade for Alcohol Use Disorder (AUD)

  • NCT04396873 · 184 participants · Phase 1

    PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04059718, the US trial registry maintained by the National Library of Medicine. NCT04059718 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.